Meridian Bioscience Inc 's

Name: Meridian Bioscience Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VIVO Sales vs. its Competitors Q2 2022

Comparing the current results to its competitors, Meridian Bioscience Inc reported Revenue decrease in the 2 quarter 2022 year on year by -35.59 %, faster than the overall decrease of Meridian Bioscience Inc 's competitors by -35.45 %, recorded in the same quarter.

• List of VIVO Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Meridian Bioscience Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< VIVO Stock Performance Comparisons

<< See the full list of VIVO competitors

Overall company Market Share Q2 2022

Overall company, revenue fell by -35.59 % company lost market share within this segment. << More on VIVO Market Share.

*Market share is calculated based on total revenue.

VIVO's Stock Performance relative to its Competitors

Publicly Traded Peers of Meridian Bioscience Inc

Endonovo Therapeutics Inc
Share Performance

0.00%

One Year

Endonovo Therapeutics Inc

Profile

Endonovo Therapeutics Inc is a biotechnology company focused on the development of non-invasive electroceuticals for regenerative therapies. Their business model centers around the research, development, and commercialization of their innovative technology that stimulates the body's natural healing process. With a focus on treating inflammatory conditions and diseases, Endonovo aims to provide advanced, non-pharmaceutical solutions for improved patient outcomes.

More about Endonovo Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 0.135 mill.	$ 0.256 mill.	$ -4.404 mill.

Sources: Meridian Bioscience Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, August 30, 2026 12:55 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Meridian Bioscience Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.